The imaging and neuropathological effects of Bevacizumab (Avastin) in patients with leptomeningeal carcinomatosis

Journal of Neuro-Oncology

Volumn 96, Issue 3, 2010, Pages 375-384

  Kleinschmidt Demasters, B K ^a,b   Damek, Denise M ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Anti angiogenic; Carcinomatous meningitis; Neuroimaging; Vasculopathy; White matter

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; CARCINOEMBRYONIC ANTIGEN; DEXAMETHASONE; GEMCITABINE; PACLITAXEL; TEMOZOLOMIDE;

ADULT; ANAMNESIS; ARTICLE; AUTOPSY; BONE METASTASIS; BRAIN BIOPSY; BRAIN METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CARCINOMATOUS MENINGITIS; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; CRANIOTOMY; DEMENTIA; DIZZINESS; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; FALLING; FEMALE; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMAGE ANALYSIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MALE; MASTECTOMY; MEMORY DISORDER; MULTIPLE CYCLE TREATMENT; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PETECHIA; PLASTIC SURGERY; PROGNOSIS; SEIZURE; SPINE METASTASIS; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT REFUSAL; UNSTEADINESS; VASCULAR DISEASE; WHITE MATTER;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; AUTOPSY; BRAIN; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MALE; MENINGEAL CARCINOMATOSIS; MIDDLE AGED;

EID: 75049084109     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9969-2     Document Type: Article

References (30)

1. L Yan K Hsu RA Beckman 2008 Antibody-based therapy for solid tumors Cancer J 14 178 183 10.1097/PPO.0b013e318172d71a 1:CAS:528:DC%2BD1cXotlWlsLg%3D 18536557
2. SS Lynch CM Cheng 2007 Bevacizumab for neovascular ocular diseases Ann Pharmacother 41 614 625 10.1345/aph.1H316 1:CAS:528:DC%2BD2sXltlOnsrs%3D 17355998 (Pubitemid 46625484)
3. J Simonds F Miller J Mandel TM Davidson 2009 The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia Laryngoscope 119 988 992 10.1002/lary.20159 1:CAS:528:DC%2BD1MXntFWltLg%3D 19194865
4. Torcuator R, Zuniga R, Mohan Y, Rock J, Doyle T, Anderson J, Gutierrez J, Ryu S, Jain R, Rosenblum M, Mikkelsen T (2009) Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol. doi: 10.1007/s11060-009-9801-z
5. AD Norden J Drappatz PY Wen 2008 Novel anti-angiogenic therapies for malignant gliomas Lancet Neurol 7 1152 1160 10.1016/S1474-4422(08)70260-6 1:CAS:528:DC%2BD1cXhsFCrsLvO 19007739
6. J Dietrich AD Norden PY Wen 2008 Emerging antiangiogenic treatments for gliomas-efficacy and safety issues Curr Opin Neurol 21 736 744 10.1097/WCO.0b013e3283131370 1:CAS:528:DC%2BD1MXkt1GksA%3D%3D 19060566
7. Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL, Lymberis S, Yamada Y, Chang J, Abrey LE (2008) Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. doi: 10.1016/j.ijrobp.2008.10.043
8. MC Chamberlain S Johnston 2009 Bevacizumab for recurrent alkylator-refractory anaplastic oligodendroglioma Cancer 115 1734 1743 10.1002/cncr.24179 1:CAS:528:DC%2BD1MXltVOnurw%3D 19197992
9. PL Nghiemphu W Liu Y Lee T Than C Graham A Lai RM Green WB Pope LM Liau PS Mischel SF Nelson R Elashoff TF Cloughesy 2009 Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience Neurology 72 1217 1222 10.1212/01.wnl.0000345668.03039.90 1:CAS:528:DC%2BD1MXjslKrsrs%3D 19349600
10. JJ Vredenburgh A Desjardins JE Herndon J Marcello DA Reardon JA Quinn JN Rich S Sathornsumetee S Gururangan J Sampson M Wagner L Bailey DD Bigner AH Friedman HS Friedman 2007 Bevacizumab plus irinotecan in recurrent glioblastoma multiforme J Clin Oncol 25 4722 4729 10.1200/JCO.2007.12.2440 1:CAS:528:DC%2BD2sXhtlCgsLjF 17947719 (Pubitemid 350086473)
11. JL Rubenstein J Kim T Ozawa M Zhang M Westphal DF Deen MA Shuman 2000 Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption Neoplasia 2 306 314 10.1038/sj.neo.7900102 1:CAS:528:DC%2BD3cXntVCjtb8%3D 11005565
12. E Kokmen JM Naessens KP Offord 1987 A short test of mental status: description and preliminary results Mayo Clin Proc 62 281 288 1:STN:280:DyaL2s7ntFGhtQ%3D%3D 3561043
13. MF Folstein SE Folstein PR McHugh 1975 "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189 198 10.1016/0022-3956(75)90026-6 1:STN:280: DyaE28%2FntFKjtw%3D%3D 1202204
14. R Dubois A Scacheysky I Lityan B Pillon 2000 The FAB: A fronal assessment battery at bedside Neurology 55 1621 1628 1:STN:280:DC%2BD3M%2FnvFSrsA%3D%3D 11113214
15. I Fischer CH Cunliffe RJ Bollo S Raza D Monoky L Chiriboga EC Parker JG Golfinos PJ Kelly EA Knopp ML Gruber D Zagzag A Narayana 2008 High-grade glioma before and after treatment with radiation and Avastin: initial observations Neuro Oncol 10 700 708 10.1215/15228517-2008-042 18697955
16. MS Mathews ME Linskey AN Hasso JP Fruehauf 2008 The effect of bevacizumab (Avastin) on neuroimaging of brain metastases Surg Neurol 70 649 652 10.1016/j.surneu.2007.06.029 18261776
17. Yachnis AT (2005) Vascular disease. In: Prayson RA (ed) Neuropathology. Elsevier Churchill Livingstone, Philadelphia, PA, pp 46-49 2005
18. ME Olson NL Chernik JB Posner 1974 Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study Arch Neurol 30 122 137 1:STN:280:DyaE2c%2FosFyqsQ%3D%3D 4405841
19. WR Wasserstrom JP Glass JB Posner 1982 Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients Cancer 49 759 772 10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0. CO;2-7 1:STN:280:DyaL387hsV2ltw%3D%3D 6895713
20. S Kastenbauer M Wiesmann H-W Pfister 2000 Cerebral vasculopathy and multiple infarctions in a woman with carcinomatous meningitis while on treatment with intrathecal methotrexate J Neurooncol 48 41 45 10.1023/A:1006448311976 1:STN:280:DC%2BD3cvns1WlsQ%3D%3D 11026695
21. DH Guttman CR Cantor GJ Piacente LF McCluskey 1990 Cerebral vasculopathy and infarction in a woman with carcinomatous meningitis J Neurooncol 9 183 185 10.1007/BF02427841
22. P Klein EC Haley GF Wooten SR VandenBerg 1989 Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases Arch Neurol 46 1149 1152 1:STN:280:DyaK3c%2FisF2isQ%3D%3D 2552969
23. R Solans-Laque JA Bosch-Gil C Perez-Bocanegra A Selva-O'Callaghan CP Simeon-Aznar M Vilardell-Tarres 2008 Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases J Rheumatol 35 294 304 18085729
24. FS Taccone I Salmon R Marechal SA Blecic 2007 Paraneoplastic vasculitis of central nervous system presenting as recurrent cryptogenic stroke Int J Clin Oncol 12 155 159 10.1007/s10147-006-0631-0 17443285 (Pubitemid 46632457)
25. JP Geisler DF Schraith KJ Manahan JI Sorosky 2004 Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal cancer Gynecol Oncol 92 705 707 10.1016/j.ygyno.2003.10.050 14766271 (Pubitemid 38183168)
26. S Niho K Kubota K Goto H Ohmatsu T Matsumoto R Kakinuma Y Nishiwaki 2002 Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study Br J Cancer 87 1360 1364 10.1038/sj.bjc.6600658 1:CAS:528:DC%2BD38XovFKrsbk%3D 12454762 (Pubitemid 36044308)
27. M Birlik S Akar E Tuzel F Onen E Ozer M Manisali Z Kirkali N Akkoc 2004 Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder J Cancer Res Clin Oncol 130 122 125 10.1007/s00432-003-0529-4 1:CAS:528:DC%2BD2cXhtlehsLg%3D 14745551 (Pubitemid 38316676)
28. AM Voorburg FT van Beek PH Slee CA Seldenrijk FM Schramel 2002 Vasculitis due to gemcitabine Lung Cancer 36 203 205 10.1016/S0169-5002(01)00464-0 1:STN:280:DC%2BD383hvFymtg%3D%3D 11955656 (Pubitemid 34296563)
29. C Ozcan SJ Wong P Hari 2006 Reversible posterior leukoencephalopathy syndrome and bevacizumab N Engl J Med 354 980 982 10.1056/NEJMc052954 16514715 (Pubitemid 43313687)
30. CF Levy KZ Oo F Fireman L Pierre MA Bania S Sadanandan DJ Yamashiro JL Bender 2008 Reversible posterior leukoencephalopathy syndrome in a child treated with bevacizumab Pediatr Blood Cancer 52 669 671 10.1002/pbc.21866 2009